ArticlePlant biotechnology journal2026
Chromosome-Level Genome Assembly of the Allotetraploid Gynostemma pentaphyllum Provides Novel Insights Into the Biosynthesis of Ginsenoside and Gypenoside LVI.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Gynostemma pentaphyllum, a herb used in tea and traditional Chinese medicine, shows geographic variation in its production of valuable dammarane-type ginsenosides and gypenoside LVI between populations from Suining (SN) and Nanning (NN). To elucidate the mechanisms underlying this differential metabolite accumulation, a chromosome-level genome for G. pentaphyllum (SN population) was assembled. The analysis revealed that SN is a tetraploid (~1.2 Gb), resulting from a recent whole-genome duplication event in a diploid ancestor. Phylogenetic analysis indicates SN and diploid NN share a recent common ancestor, diverging approximately 4.95 million years ago. Chromosome evolution analysis confirmed SN is an allotetraploid with clear subgenomic differentiation. This genome, combined with multi-omics data, enabled the screening of candidate P450 genes involved in ginsenoside/gypenoside LVI biosynthesis. In vivo and in vitro experiments confirmed that GpCYP88AB3 functions as a bifunctional enzyme by first hydroxylating dammarenediol-II at C-12 to yield protopanaxadiol (PPD), and then hydroxylating PPD at C-2 to form 2α-OH-PPD. Phylogenetically, GpCYP88AB3 and similar enzymes from Araliaceae belong to distinct CYP subfamilies, demonstrating convergent evolution of this function between the two plant families and highlighting the functional plasticity of P450s. Evolutionary analysis suggests that GpCYP88AB3 emerged from a CYP88 gene family expansion in the tetraploid G. pentaphyllum. This expansion occurred after, but was not directly caused by, the whole-genome duplication event. This study elucidates the biosynthetic pathway for the key metabolites in G. pentaphyllum, providing a foundation for future metabolic engineering and synthetic biology applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.